1. G. Hahn, H.D. Lehmann, M. Kürten, H. Uebel and G. Vogel, Arzneimittel-Forsch.18, 698 (1968). —G. Vogel, W. Trost, R. Braatz, K.P. Odenthal, G. Brüsewitz, H. Antweiler and R. Seeger, Arzneimittel-Forsch.25, 82, 179 (1975). —R. Braatz and C.C. Schneider, eds: Symposium on the Pharmacodynamics of Silymarin. Urban & Schwarzenberg, München-Berlin-Wien 1976.
2. H. Wagner, P. Diesel and M. Seitz, Arzneimittel-Forsch.24, 466 (1974).
3. H.M. Rauen, H. Schriewer, U. Tegtbauer and J.F. Lasana, Experientia29, 1372 (1973); Arzneimittel-Forsch.23, 145 (1973). — H. Schriewer and H.M. Rauen, Arzneimittel-Forsch.26, 235 (1976).
4. A. Bindoli, L. Cavallini and N. Siliprandi, Epatologia23, 219 (1977); Biochem. Pharmac.26, 2405 (1977); Pharmac. Res. Commun.10, 133 (1978).
5. E. Castigli, I. Mezzasoma, D. Marini and G. Porcellati, Annali Fac. Med. Chir. Univ. Perugia67, 15 (1976). — E. Castigli, I. Montanini, R. Robert and G. Porcellati, Pharmac. Res. Commun.9, 59 (1977). — I. Montanini, E. Castigli, U.G. Arienti and G. Porcellati, Farmaco, ed. sci.32, 141 (1977).